Insurer Strategies to Control Costs Associated with Weight Loss Drugs

Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a an analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription drug plans for Ozempic, which…More

Read the full post on Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation

Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation